arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

Embecta Corp.

EMBC
$5.59 ▼ -0.01 (-0.18%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
25 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
63
Health
Fair
Bullish
auto_awesome

Analytical Summary

Embecta Corp. shows strong fundamentals with top-quartile Debt to Equity and Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $326.9M
Dividend Yield 0.18%
Revenue Growth -8.1%
Op. Margin 17.9%
ROIC 5.3%
FCF / Share $0.70
Trailing P/E 15.5x
Price / Book
FCF Yield 12.5%
Debt / Equity -2.15
info Valuation on last close. End-of-day price, Sep 23, 2026.

25-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$271.70M
↓ -8.1%
Net Income Profit after all expenses
$21.10M
↓ -53.6%
Operating Margin Operating profit as % of sales
17.9%
↑ +13.6% 78th
FCF / Share Free cash flow per share
$0.70
↑ +34.9%
Long-Term Debt Long-term obligations
$1.32B
— -0.1%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Operating Margin (%)Operating Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
72
Returns
31
Financial Health
81
Cash Quality
85

Dividend History

Dividend / share · sourced from SEC filings
$0.60 Latest / share
+0.0% YoY
+58.7% 4-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 25 quarters